The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

J A Kemp

Work 020 3077 8600
Fax 020 7430 1000
Cambridge, London, Munich, Oxford, Paris

Simon Wright

Work +44 20 3077 8600
J A Kemp

Work Department

Biotechnology and life sciences.


Partner, European Patent Attorney, UK Chartered Patent Attorney


Simon has over 25 years' experience of patent work, including drafting, filing and prosecuting patent applications throughout the world, but in particular before the European Patent Office (EPO). Simon also handles opposition and appeal work, primarily in the life sciences area.

His technical work has covered pharmaceuticals and vaccines, insulin inhalers, fermentation technology, as well as pharmaceutical and nutritional uses of polyunsaturated fatty acids (PUFAs), astaxanthin, and Vitamin B12. He also handles cases on gene therapy, CRISPR technology, botilinum toxin compositions, personalised nutrition, biofuels, nanoparticle/liposome formulations, biomarkers, micro-arrays and stem cells.

Simon's clients range from European multinational companies to small UK academic organisations and SMEs.

He has been involved in oppositions and appeals concerning human pheromones, Hoffman-La Roche's PCR patents, ultrasound contrast agents, medical devices (for measuring glucose levels), nutritional uses of arachidonic acid (ARA), vaccines and anti-prolactin agents.

Simon was involved in the seminal EPO Board of Appeal Decision T820/92 concerning contraceptive methods using LHRH.

He also acted as an expert witness, and so gave evidence to the UK High Court, in the HGS vs Eli Lilly litigation, which led to the first ever Supreme Court decision on the standard of industrial applicability.

Simon joined J A Kemp in 1994, after working elsewhere in private practice since 1986, and became a partner in 1999.


Member of the Institute of Professional Representatives before the European Patent Office (EPI), Chairman of the CIPA Life Sciences Committee, Secretary of the EPI Biotechnological Inventions Committee, Member of the CIPA Council, UK Member of EPI Council, Member of the Standing Advisory Committee before the European Patent Office (SACEPO), UK Member of EPI Governing Board


Bristol University (Hons, Chemistry (with Biochemistry options)).

London: TMT (technology, media and telecoms)

PATMA: Patent attorneys

Within: PATMA: Patent attorneys

J A Kemp is 'extremely meticulous in fully understanding the business context, strategies and needs' of its clients, which include NBCUniversal, University of Vienna and Pharma UK. Celia Keen is head of the chemistry and pharmaceuticals team and has extensive experience in drafting and prosecuting patents. The 'excellent' Mark Roberts is 'very knowledgeable about European patent prosecution' and 'offers prompt and appropriate advice'. Other key team members are Patrick Campbell, Kieron Grehan, Andrew Webb, and Simon Wright, who are all 'excellent lawyers'. Key mandates included Chris Milton advising Semblant on the management of its patent portfolio and Amanda Simons assisting F2G with the drafting and prosecution of its new patent applications. Other recommended individuals include Ravi Srinivasan, John Leeming, Andrew Bentham, Sarah Roques, and Graham Lewis.

[back to top]

Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • The legal difference between a consultant and an employee according to Nicaraguan Law

    Knowing the legal difference between a consultant and an employee is important for a company that needs to hire someone in Nicaragua or for a person interested in rendering services for a company or another person, due to the fact that the nature of the contractual relationship will determine many factors that both parties must be aware of before executing the contracting modality that will govern the relationship between them - the nature of the contractual relationship impacts on the employment benefits, tax implications and liabilities that the parties must comply with according to the law.  labor_law_in_nicaragua
  • Single director - shareholder Companies according to the Nicaraguan legal system

    What is a Single Shareholder and Director legal entity?
  • Business in Nicaragua- The Most Important Changes in the Recent Tax Reform

    In recent years, the country ŐĀs the government has been committed to improving Taxation in Nicaragua and attempting to follow the legislative model used by some of the other countries in the region. Starting January 1st, 2013, a new tax law (Law No. 822, Tax Concertation Law) came into force in and completely changed the taxation system in Nicaragua. Two years later a new law was issued by the National Assembly containing more than 80 amendments, additions and repeals (Law No 891) which came into force December 18th, 2014.